A study of more than 800 type 2 diabetes patients revealed those who used dapagliflozin as an add-on to insulin and other diabetes medicines lost more weight and reduced insulin use compared with those who took a placebo. The findings appear in the Annals of Internal Medicine.
Dapagliflozin shows efficacy in glucose, weight control
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||